Application 103951
- Type
- BLA
- Sponsor
- AMGEN
Purple Book Biologic Products#
| BLA | Proprietary name | Proper name | License type | Status | Latest source |
|---|---|---|---|---|---|
| 103951 | Aranesp | darbepoetin alpha | 351(a) | Rx | 2026-06-01 |
Application Products#
| Product | Drug | Ingredient | Form | Strength | Reference drug | Reference standard |
|---|---|---|---|---|---|---|
| 001 | ARANESP | DARBEPOETIN ALFA | VIAL; INTRAVENOUS | 25UG/ML | No | No |
| 002 | ARANESP | DARBEPOETIN ALFA | VIAL; INTRAVENOUS | 40UG/ML | No | No |
| 003 | ARANESP | DARBEPOETIN ALFA | VIAL; INTRAVENOUS | 60UG/ML | No | No |
| 004 | ARANESP | DARBEPOETIN ALFA | VIAL; INTRAVENOUS | 100UG/ML | No | No |
| 005 | ARANESP | DARBEPOETIN ALFA | VIAL; INTRAVENOUS | 200UG/ML | No | No |
| 006 | ARANESP | DARBEPOETIN ALFA | VIAL; SUBCUTANEOUS | 25UG/ML | No | No |
| 007 | ARANESP | DARBEPOETIN ALFA | VIAL; SUBCUTANEOUS | 40UG/ML | No | No |
| 008 | ARANESP | DARBEPOETIN ALFA | VIAL; SUBCUTANEOUS | 60UG/ML | No | No |
| 009 | ARANESP | DARBEPOETIN ALFA | VIAL; SUBCUTANEOUS | 100UG/ML | No | No |
| 010 | ARANESP | DARBEPOETIN ALFA | VIAL; SUBCUTANEOUS | 200UG/ML | No | No |
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| ARANESP | DARBEPOETIN ALFA | Amgen, Inc | 0fd36cb9-c4f6-4167-93c9-8530865db3f9 | 2026-07-07 | Boxed warning, Warnings, Adverse reactions | BLA103951 55513-023 55513-025 55513-111 55513-004 55513-098 55513-003 55513-028 55513-005 55513-002 55513-032 55513-021 55513-057 55513-027 55513-006 |
NDC Listings For This Application#
| NDC | Name | Nonproprietary name | Labeler | Marketing category | Status |
|---|---|---|---|---|---|
| 55513-002 | ARANESP | darbepoetin alfa | Amgen Inc | BLA | Current |
| 55513-002 | ARANESP | darbepoetin alfa | Amgen Inc | BLA | Current |
| 55513-002 | ARANESP | darbepoetin alfa | Amgen Inc | BLA | Current |
| 55513-003 | ARANESP | darbepoetin alfa | Amgen Inc | BLA | Current |
| 55513-003 | ARANESP | darbepoetin alfa | Amgen Inc | BLA | Current |
| 55513-003 | ARANESP | darbepoetin alfa | Amgen Inc | BLA | Current |
| 55513-004 | ARANESP | darbepoetin alfa | Amgen Inc | BLA | Current |
| 55513-004 | ARANESP | darbepoetin alfa | Amgen Inc | BLA | Current |
| 55513-004 | ARANESP | darbepoetin alfa | Amgen Inc | BLA | Current |
| 55513-005 | ARANESP | darbepoetin alfa | Amgen Inc | BLA | Current |
| 55513-005 | ARANESP | darbepoetin alfa | Amgen Inc | BLA | Current |
| 55513-005 | ARANESP | darbepoetin alfa | Amgen Inc | BLA | Current |
| 55513-006 | ARANESP | darbepoetin alfa | Amgen Inc | BLA | Current |
| 55513-006 | ARANESP | darbepoetin alfa | Amgen Inc | BLA | Current |
| 55513-006 | ARANESP | darbepoetin alfa | Amgen Inc | BLA | Current |
| 55513-021 | ARANESP | darbepoetin alfa | Amgen Inc | BLA | Current |
| 55513-021 | ARANESP | darbepoetin alfa | Amgen Inc | BLA | Current |
| 55513-021 | ARANESP | darbepoetin alfa | Amgen Inc | BLA | Current |
| 55513-023 | ARANESP | darbepoetin alfa | Amgen Inc | BLA | Current |
| 55513-023 | ARANESP | darbepoetin alfa | Amgen Inc | BLA | Current |
| 55513-023 | ARANESP | darbepoetin alfa | Amgen Inc | BLA | Current |
| 55513-025 | ARANESP | darbepoetin alfa | Amgen Inc | BLA | Current |
| 55513-025 | ARANESP | darbepoetin alfa | Amgen Inc | BLA | Current |
| 55513-025 | ARANESP | darbepoetin alfa | Amgen Inc | BLA | Current |
| 55513-027 | ARANESP | darbepoetin alfa | Amgen Inc | BLA | Current |
| 55513-027 | ARANESP | darbepoetin alfa | Amgen Inc | BLA | Current |
| 55513-027 | ARANESP | darbepoetin alfa | Amgen Inc | BLA | Current |
| 55513-028 | ARANESP | darbepoetin alfa | Amgen Inc | BLA | Current |
| 55513-028 | ARANESP | darbepoetin alfa | Amgen Inc | BLA | Current |
| 55513-028 | ARANESP | darbepoetin alfa | Amgen Inc | BLA | Current |
| 55513-032 | ARANESP | darbepoetin alfa | Amgen Inc | BLA | Current |
| 55513-032 | ARANESP | darbepoetin alfa | Amgen Inc | BLA | Current |
| 55513-032 | ARANESP | darbepoetin alfa | Amgen Inc | BLA | Current |
| 55513-057 | ARANESP | darbepoetin alfa | Amgen Inc | BLA | Current |
| 55513-057 | ARANESP | darbepoetin alfa | Amgen Inc | BLA | Current |
| 55513-057 | ARANESP | darbepoetin alfa | Amgen Inc | BLA | Current |
| 55513-098 | ARANESP | darbepoetin alfa | Amgen Inc | BLA | Current |
| 55513-098 | ARANESP | darbepoetin alfa | Amgen Inc | BLA | Current |
| 55513-098 | ARANESP | darbepoetin alfa | Amgen Inc | BLA | Current |
| 55513-110 | ARANESP | darbepoetin alfa | Amgen Inc | BLA | Current |
| 55513-110 | ARANESP | darbepoetin alfa | Amgen Inc | BLA | Current |
| 55513-110 | ARANESP | darbepoetin alfa | Amgen Inc | BLA | Current |
| 55513-111 | ARANESP | darbepoetin alfa | Amgen Inc | BLA | Current |
| 55513-111 | ARANESP | darbepoetin alfa | Amgen Inc | BLA | Current |
| 55513-111 | ARANESP | darbepoetin alfa | Amgen Inc | BLA | Current |
Documents#
| Document | Submission type | Date |
|---|---|---|
| 78338 | SUPPL | 2024-05-02 |
| 78331 | SUPPL | 2024-05-01 |
| 39760 | SUPPL | 2019-06-05 |
| 57583 | SUPPL | 2019-02-13 |
| 57388 | SUPPL | 2019-01-31 |
| 56981 | SUPPL | 2018-12-21 |
| 56980 | SUPPL | 2018-12-21 |
| 50308 | SUPPL | 2017-11-06 |
| 50247 | SUPPL | 2017-10-31 |
| 48043 | SUPPL | 2017-04-14 |
| 48014 | SUPPL | 2017-04-14 |
| 31742 | SUPPL | 2016-04-28 |
| 31741 | SUPPL | 2015-07-24 |
| 18710 | SUPPL | 2014-01-07 |
| 18709 | SUPPL | 2014-01-07 |
| 31739 | SUPPL | 2014-01-02 |
| 9517 | SUPPL | 2014-01-02 |
| 31740 | SUPPL | 2013-03-29 |
| 22765 | SUPPL | 2012-07-16 |
| 18708 | SUPPL | 2012-06-06 |
| 9516 | SUPPL | 2012-06-04 |
| 24355 | SUPPL | 2012-05-25 |
| 22764 | SUPPL | 2011-12-02 |
| 31738 | SUPPL | 2011-06-24 |
| 18707 | SUPPL | 2011-06-24 |
| 18705 | SUPPL | 2011-06-24 |
| 9515 | SUPPL | 2011-06-24 |
| 9514 | SUPPL | 2011-06-24 |
| 31735 | SUPPL | 2011-04-28 |
| 31736 | SUPPL | 2010-02-16 |
| 18706 | SUPPL | 2010-02-16 |
| 31737 | SUPPL | 2010-02-05 |
| 39758 | SUPPL | 2010-02-04 |
| 39757 | SUPPL | 2010-02-04 |
| 39756 | SUPPL | 2008-11-26 |
| 31734 | SUPPL | 2008-03-13 |
| 43576 | SUPPL | 2008-03-12 |
| 39755 | SUPPL | 2008-03-11 |
| 31733 | SUPPL | 2008-01-31 |
| 18704 | SUPPL | 2008-01-30 |
| 31732 | SUPPL | 2007-11-08 |
| 23082 | SUPPL | 2007-11-08 |
| 18703 | SUPPL | 2007-11-08 |
| 31730 | SUPPL | 2007-04-20 |
| 18701 | SUPPL | 2007-04-20 |
| 31731 | SUPPL | 2007-03-15 |
| 18702 | SUPPL | 2007-03-09 |
| 31729 | SUPPL | 2006-04-05 |
| 18700 | SUPPL | 2006-04-05 |
| 39754 | SUPPL | 2006-02-08 |
| 9512 | SUPPL | 2006-02-08 |
| 18699 | SUPPL | 2005-12-16 |
| 9513 | SUPPL | 2005-12-16 |
| 18698 | SUPPL | 2005-01-26 |
| 9511 | SUPPL | 2005-01-26 |
| 43575 | SUPPL | 2004-09-22 |
| 39753 | SUPPL | 2004-03-11 |
| 31728 | SUPPL | 2004-03-11 |
| 31727 | ORIG | 2004-01-21 |
| 22763 | ORIG | 2004-01-21 |
| 18697 | ORIG | 2004-01-21 |
| 52597 | SUPPL | 1900-01-01 |
| 52596 | SUPPL | 1900-01-01 |